My name is Arturo Eligan. I am working in Kabul, Afghanistan as an Intergovernmental panel physician. I have diagnosed a case of INH-only resistant TB case through Culture and Sensitivity. In compliance with WHO and ATS / CDC Guidelines (Not to treat MDR TB in Stand-alone DOTS clinics) I referred this patient to a JICA-supported regional reference MDR TB clinic. This patient came to me the other day and I was surprised with the medicines she is taking : She is on PO- Ethionamide, Rifampicin, PZA, Ethambutol, LevoFloxacin and IM -Amikacin. I went back to the WHO Guidelines and didn't see these regimen as the recommended for INH-only resistant TB. Practically this is an MDR regimen minus the Rifampicin. I will appreciate if you guys who have experience with INH-resistant cases could shed light on this. Thank you.